Literature DB >> 30351923

Potent, Irreversible Inhibition of Human Carboxylesterases by Tanshinone Anhydrides Isolated from Salvia miltiorrhiza ("Danshen").

M Jason Hatfield1, Randall J Binder1, Rowan Gannon1, Ellie M Fratt1, John Bowling1, Philip M Potter1.   

Abstract

The roots of Salvia miltiorrhiza ("Danshen") have been used in Chinese herbal medicine for centuries for a host of different conditions. While the exact nature of the active components of this material are unknown, large amounts of tanshinones are present in extracts derived from these samples. Recently, the tanshinones have been demonstrated to be potent human carboxylesterase (CE) inhibitors, with the ability to modulate the biological activity of esterified drugs. During the course of these studies, we also identified more active, irreversible inhibitors of these enzymes. We have purified, identified, and synthesized these molecules and confirmed them to be the anhydride derivatives of the tanshinones. These compounds are exceptionally potent inhibitors ( Ki < 1 nM) and can inactivate human CEs both in vitro and in cell culture systems and can modulate the metabolism of the esterified drug oseltamivir. Therefore, the coadministration of Danshen extracts with drugs that contain the ester chemotype should be minimized since, not only is transient inhibition of CEs observed with the tanshinones, but also prolonged irreversible inhibition arises via interaction with the anhydrides.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30351923      PMCID: PMC6263802          DOI: 10.1021/acs.jnatprod.8b00378

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  24 in total

1.  Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1.

Authors:  J Zhang; J C Burnell; N Dumaual; W F Bosron
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

2.  Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel.

Authors:  Deshi Shi; Jian Yang; Dongfang Yang; Edward L LeCluyse; Chris Black; Li You; Fatemeh Akhlaghi; Bingfang Yan
Journal:  J Pharmacol Exp Ther       Date:  2006-09-11       Impact factor: 4.030

3.  Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicity.

Authors:  Janice L Hyatt; Lyudmila Tsurkan; Monika Wierdl; Carol C Edwards; Mary K Danks; Philip M Potter
Journal:  Mol Cancer Ther       Date:  2006-09       Impact factor: 6.261

Review 4.  Carboxylesterases: General detoxifying enzymes.

Authors:  M Jason Hatfield; Robyn A Umans; Janice L Hyatt; Carol C Edwards; Monika Wierdl; Lyudmila Tsurkan; Michael R Taylor; Philip M Potter
Journal:  Chem Biol Interact       Date:  2016-02-15       Impact factor: 5.192

Review 5.  Mammalian carboxylesterases: from drug targets to protein therapeutics.

Authors:  Matthew R Redinbo; Philip M Potter
Journal:  Drug Discov Today       Date:  2005-03-01       Impact factor: 7.851

6.  Methylphenidate is stereoselectively hydrolyzed by human carboxylesterase CES1A1.

Authors:  Zejin Sun; Daryl J Murry; Sonal P Sanghani; Wilhelmina I Davis; Natalia Y Kedishvili; Qin Zou; Thomas D Hurley; William F Bosron
Journal:  J Pharmacol Exp Ther       Date:  2004-04-13       Impact factor: 4.030

7.  Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity.

Authors:  Randy M Wadkins; Janice L Hyatt; Kyoung Jin P Yoon; Christopher L Morton; Richard E Lee; Komath Damodaran; Paul Beroza; Mary K Danks; Philip M Potter
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

8.  Selective Inhibitors of Human Liver Carboxylesterase Based on a β-Lapachone Scaffold: Novel Reagents for Reaction Profiling.

Authors:  M Jason Hatfield; Jingwen Chen; Ellie M Fratt; Liying Chi; John C Bollinger; Randall J Binder; John Bowling; Janice L Hyatt; Jerrod Scarborough; Cynthia Jeffries; Philip M Potter
Journal:  J Med Chem       Date:  2017-02-07       Impact factor: 8.039

Review 9.  Pharmacokinetics and molecular detoxication.

Authors:  J R Cashman; B Y Perotti; C E Berkman; J Lin
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

10.  Synthetic methods for the preparation of ARQ 501 (beta-Lapachone) human blood metabolites.

Authors:  Rui-Yang Yang; Darin Kizer; Hui Wu; Erika Volckova; Xiu-Sheng Miao; Syed M Ali; Manish Tandon; Ronald E Savage; Thomas C K Chan; Mark A Ashwell
Journal:  Bioorg Med Chem       Date:  2008-04-01       Impact factor: 3.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.